SELECTBIO - Immuno-Oncology Europe 2019 Biographies

Home

Agenda

Keynote Speakers

Registration

Exhibition

Venue

Training Courses

Single-Cell Secretion Cytokine Signatures – Enhanced Tools For Therapeutic Design and Prediction of Clinical Response

Monday, 28 October 2019 at 17:30

Add to Calendar ▼2019-10-28 17:30:002019-10-28 18:30:00Europe/LondonSingle-Cell Secretion Cytokine Signatures – Enhanced Tools For Therapeutic Design and Prediction of Clinical ResponseImmuno-Oncology Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

We will present data showing how polyfunctionality measured by IsoPlexis, correlates with patient objective response, can be used to enhance pre-clinical development across CAR-T and combination therapies.

Miles Rackliff, Senior Sales Manager – Northern Europe, IsoPlexis

For the last twenty years, Miles has specialized in providing novel and innovative technologies to help advance life science research and drug discovery. 2019 has seen Miles enable access to the unique IsoPlexis technology in the UK and Northern Europe.